Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting
- PMID: 11350815
- DOI: 10.1152/ajplung.2001.280.6.L1335
Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting
Abstract
Vascular immunotargeting is a mean for a site-selective delivery of drugs and genes to endothelium. In this study, we compared recognition of pulmonary and systemic vessels in rats by candidate carrier monoclonal antibodies (MAbs) to endothelial antigens platelet endothelial cell adhesion molecule (PECAM)-1 (CD31), intercellular adhesion molecule (ICAM)-1 (CD54), Thy-1.1 (CD90.1), angiotensin-converting enzyme (ACE; CD143), and OX-43. Tissue immunostaining showed that endothelial cells were Thy-1.1 positive in capillaries but negative in large vessels. In the lung, anti-ACE MAb provided a positive staining in 100% capillaries vs. 5-20% capillaries in other organs. Other MAbs did not discriminate between pulmonary and systemic vessels. We determined tissue uptake after infusion of 1 microg of (125)I-labeled MAbs in isolated perfused lungs (IPL) or intravenously in intact rats. Uptake in IPL attained 46% of the injected dose (ID) of anti-Thy-1.1 and 20-25% ID of anti-ACE, anti-ICAM-1, and anti-OX-43 (vs. 0.5% ID of control IgG). However, after systemic injection at this dose, only anti-ACE MAb 9B9 displayed selective pulmonary uptake (16 vs. 1% ID/g in other organs). Anti-OX-43 displayed low pulmonary (0.5% ID/g) but significant splenic and cardiac uptake (7 and 2% ID/g). Anti-Thy-1.1 and anti-ICAM-1 displayed moderate pulmonary (4 and 6% ID/g, respectively) and high splenic and hepatic uptake (e.g., 18% ID/g of anti-Thy-1.1 in spleen). The lung-to-blood ratio was 5, 10, and 15 for anti-Thy-1.1, anti-ACE, and anti-ICAM-1, respectively. PECAM antibodies displayed low pulmonary uptake in perfusion (2% ID) and in vivo (3-4% ID/g). However, conjugation with streptavidin (SA) markedly augmented pulmonary uptake of anti-PECAM in perfusion (10-54% ID, depending on an antibody clone) and in vivo (up to 15% ID/g). Therefore, ACE-, Thy-1.1-, ICAM-1-, and SA-conjugated PECAM MAbs are candidate carriers for pulmonary targeting. ACE MAb offers a high selectivity of pulmonary targeting in vivo, likely because of a high content of ACE-positive capillaries in the lungs.
Similar articles
-
Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2379-84. doi: 10.1073/pnas.96.5.2379. Proc Natl Acad Sci U S A. 1999. PMID: 10051650 Free PMC article.
-
Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme.Pulm Pharmacol Ther. 2005;18(4):251-67. doi: 10.1016/j.pupt.2004.12.008. Pulm Pharmacol Ther. 2005. PMID: 15777608
-
Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress.Am J Physiol. 1998 Oct;275(4):L806-17. doi: 10.1152/ajplung.1998.275.4.L806. Am J Physiol. 1998. PMID: 9755114
-
[Conformational Fingerprinting Using Monoclonal Antibodies <br />(on the Example of Angiotensin I-Converting Enzyme-ACE)].Mol Biol (Mosk). 2017 Nov-Dec;51(6):1046-1061. doi: 10.7868/S0026898417060155. Mol Biol (Mosk). 2017. PMID: 29271967 Review. Russian.
-
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.ACS Nano. 2014 May 27;8(5):4100-32. doi: 10.1021/nn500136z. Epub 2014 May 7. ACS Nano. 2014. PMID: 24787360 Free PMC article. Review.
Cited by
-
Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases.Front Pharmacol. 2022 Aug 30;13:983816. doi: 10.3389/fphar.2022.983816. eCollection 2022. Front Pharmacol. 2022. PMID: 36110525 Free PMC article. Review.
-
Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting.PLoS One. 2012;7(4):e34958. doi: 10.1371/journal.pone.0034958. Epub 2012 Apr 13. PLoS One. 2012. PMID: 22514693 Free PMC article.
-
Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice.Int J Nanomedicine. 2012;7:4223-37. doi: 10.2147/IJN.S34105. Epub 2012 Aug 1. Int J Nanomedicine. 2012. PMID: 22915850 Free PMC article.
-
Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.Biomaterials. 2008 Jan;29(2):215-27. doi: 10.1016/j.biomaterials.2007.09.023. Epub 2007 Oct 24. Biomaterials. 2008. PMID: 17950837 Free PMC article.
-
Reduced expression of angiotensin I-converting enzyme in caveolin-1 knockout mouse lungs.Microvasc Res. 2010 Sep;80(2):250-7. doi: 10.1016/j.mvr.2010.04.008. Epub 2010 Apr 27. Microvasc Res. 2010. PMID: 20430040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous